IIM
IOVA icon

INTECH Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

INTECH Investment Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
109,421
-882
-0.8% -$3.35K ﹤0.01% 1387
2026
Q1 		$387K Sell
110,303
-26,460
-19% -$84.6K ﹤0.01% 1462
2025
Q4 		$373K Buy
136,763
+10,948
+9% +$25.3K ﹤0.01% 1646
2025
Q3 		$273K Sell
125,815
-45,860
-27% -$108K ﹤0.01% 1882
2025
Q2 		$295K Sell
171,675
-35,523
-17% -$88.4K ﹤0.01% 1866
2025
Q1 		$690K Buy
207,198
+59,850
+41% +$309K 0.01% 1431
2024
Q4 		$1.09M Buy
147,348
+49,390
+50% +$458K 0.01% 1080
2024
Q3 		$920K Buy
+97,958
New +$928K 0.01% 865

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

INTECH Investment Management's IOVA Position: Q2 2026 in Review

INTECH Investment Management reduced its Iovance Biotherapeutics (IOVA) stake by 0.8% in Q2 2026, selling an estimated $3.35K and leaving 109,421 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

INTECH Investment Management first reported a position in IOVA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.09M in Q4 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • INTECH Investment Management held 109,421 shares of Iovance Biotherapeutics worth $455K as of Q2 2026.
  • INTECH Investment Management sold 882 Iovance Biotherapeutics shares in Q2 2026, an estimated $3.35K.
  • Iovance Biotherapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1387 holding.
  • INTECH Investment Management first reported a position in Iovance Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Iovance Biotherapeutics position peaked at $1.09M in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.